Results 51 to 60 of about 4,642,431 (306)
BMC Pharmacology and Toxicology, 2017 Background Older people have a greater disease burden and are more likely than younger to be prescribed medications. They are also more sensitive to adverse effects.
Anna Axmon +3 more
doaj +1 more source
Dementia & Neuropsychologia, 2021 . It is important to assess the prevalence of risk factors for dementia to slow down the progression and evolution of the disease, and to support interventions and prevention programs.
Bruna Moretti Luchesi +6 more
doaj +1 more source
Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine +17 more
wiley +1 more source
National Council for the Aged: first annual report: June 1981 - December 1982. [PDF]
, 1983 In 1965 the Minister for Health appointed an Inter Departmental Committee, representing the Departments of Health, Local Government and Social Welfare, to examine and report on the general problem of the care of the aged and to make recommendations ...
National Council for the Aged.
core
Pediatric Blood &Cancer, EarlyView.ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben +4 more
wiley +1 more source
Trends in NeurosciencesMiddle age has historically been an understudied period of life compared to older age, when cognitive and brain health decline are most pronounced, but the scope for intervention may be limited. However, recent research suggests that middle age could mark a shift in brain aging. We review emerging evidence on multiple levels of analysis indicating that
Sebastian Dohm-Hansen +5 more
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Improved understanding of young and middle-aged adults about the aged people by a simulation program using braces for motion restriction [PDF]
, 2000 Fifty-four general young and middle-aged adults (mean age, 39.5 years) performed simulation of 13 actions in the aged by restricting of motor ability with cervical and short-leg braces.
酒井, 明子 +13 more
core